Waldenstrom’s Macroglobulinemia

作者: Stephen M. Ansell , Lucy S. Hodge , Suzanne R. Hayman

DOI: 10.1007/978-1-4614-8520-9_24

关键词:

摘要: Waldenstrom’s macroglobulinemia is an indolent B-cell malignancy defined by a lymphoplasmacytic infiltration in the bone marrow or other organs including lymph nodes, liver, and spleen, as well monoclonal immunoglobulin M protein (IgM) serum. The of extramedullary sites malignant B lymphocytes, elevated IgM levels, typically leads to symptoms associated with this disease. While follows course, disease remains incurable current therapy. Due heterogeneous clinical presentation, presence multiple comorbidities competing causes death, decision treat patients choice treatment can be complex many do not require initially. When therapy, it important select therapies that limit future options. To provide simple risk-adapted approach managing macroglobulinemia, rational presented.

参考文章(129)
Jan G. Waldenström, The Prognosis of Myeloma and Macroglobulinemia Annals of Life Insurance Medicine 6. pp. 93- 98 ,(1980) , 10.1007/978-3-642-67629-1_9
JORGE E. MALDONADO, ROBERT A. KYLE, ARNOLD L. BROWN, EDWIN D. BAYRD, "Intermediate" Cell Types and Mixed Cell Proliferation in Multiple Myeloma: Electron Microscopic Observations Blood. ,vol. 27, pp. 212- 226 ,(1966) , 10.1182/BLOOD.V27.2.212.212
Michael Benjamin, Sreekanth Reddy, Otis W. Brawley, Myeloma and race: a review of the literature. Cancer and Metastasis Reviews. ,vol. 22, pp. 87- 93 ,(2003) , 10.1023/A:1022268103136
Alessandra Tedeschi, Giulia Benevolo, Marzia Varettoni, Marta L. Battista, Pier L. Zinzani, Carlo Visco, Vittorio Meneghini, Pietro Pioltelli, Stefano Sacchi, Francesca Ricci, Michele Nichelatti, Francesco Zaja, Mario Lazzarino, Umbero Vitolo, Enrica Morra, Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease. Cancer. ,vol. 118, pp. 434- 443 ,(2012) , 10.1002/CNCR.26303
Eric Wattel, Isabelle Dervite, Aimery de Gramont, Pascal Lenain, Thierry Facon, Mathieu Monconduit, Francis Bauters, Pierre Morel, Bernard Grosbois, Albert Najman, Dominique Jacomy, Christine Bateli, Prognostic factors in Waldenström macroglobulinemia: a report on 232 patients with the description of a new scoring system and its validation on 253 other patients Blood. ,vol. 96, pp. 852- 858 ,(2000) , 10.1182/BLOOD.V96.3.852
Irene M. Ghobrial, Rafael Fonseca, Philip R. Greipp, Emily Blood, Montserrat Rue, David H. Vesole, Morie A. Gertz, Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study. Cancer. ,vol. 101, pp. 2593- 2598 ,(2004) , 10.1002/CNCR.20658
Elias Campo, N Lee Harris, Elaine S Jaffe, Stefano A Pileri, Harald Stein, Jurgen Thiele, James W Vardiman, None, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,(2017)
James M. Foran, Ama Z.S. Rohatiner, Bertr Coiffier, Tiziano Barbui, Stephen A. Johnson, Wolfgang Hiddemann, John A. Radford, Andrew J. Norton, Susan M. Tollerfield, Martin P. Wilson, T. Andrew Lister, Multicenter Phase II Study of Fludarabine Phosphate for Patients With Newly Diagnosed Lymphoplasmacytoid Lymphoma, Waldenström's Macroglobulinemia, and Mantle-Cell Lymphoma Journal of Clinical Oncology. ,vol. 17, pp. 546- 546 ,(1999) , 10.1200/JCO.1999.17.2.546